With the development of endoscopic technology,endoscopic submucosal dissection(ESD)has gradually replaced traditional surgery and emerged as a standard treatment for early gastric cancer.However,in recent years,the number of non-curative resection(NCR)cases has been on the rise.NCR is closely associated with local tumor recurrence,lymph node metastasis,and poor prognosis.Patients with NCR often need to receive additional treatment,thereby increasing the physical and economic burden of the patients.This article reviewed the research progress of the risk factors and management of NCR in early gastric cancer patients treated with ESD,with the aim of providing some reference for the selection of clinical treatment regimens.
维普
万方数据